Huapont Life Sciences Co Ltd (002004) — Cash Flow Reinvestment Rate
Huapont Life Sciences Co Ltd (002004) has a Cash Flow Reinvestment Rate of 0.25x as of September 2025, reinvesting CN¥160.05 Million (capex CN¥160.05 Million ) from operating cash flow of CN¥635.17 Million. Explore 002004 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huapont Life Sciences Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Huapont Life Sciences Co Ltd across 24 annual periods. Also explore 002004 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Huapont Life Sciences Co Ltd. For live market cap and broader valuation context, see how much is Huapont Life Sciences Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.32 Billion | CN¥2.10 Billion | CN¥638.28 Million | ▼ -15.1% |
| 2024 | 0.74x | CN¥1.20 Billion | CN¥1.63 Billion | CN¥956.27 Million | ▼ -21.3% |
| 2023 | 0.94x | CN¥1.50 Billion | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +32.0% |
| 2022 | 0.71x | CN¥1.72 Billion | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -41.9% |
| 2021 | 1.23x | CN¥1.56 Billion | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +51.9% |
| 2020 | 0.81x | CN¥1.92 Billion | CN¥2.37 Billion | CN¥1.23 Billion | ▲ +1.2% |
| 2019 | 0.80x | CN¥1.66 Billion | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +1.1% |
| 2018 | 0.79x | CN¥1.51 Billion | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -53.9% |
| 2017 | 1.71x | CN¥1.01 Billion | CN¥591.40 Million | CN¥972.67 Million | ▼ -76.2% |
| 2016 | 7.18x | CN¥3.68 Billion | CN¥511.90 Million | CN¥651.24 Million | ▲ +189.1% |
| 2015 | 2.48x | CN¥850.93 Million | CN¥342.45 Million | CN¥831.76 Million | ▲ +93.5% |
| 2014 | 1.28x | CN¥585.54 Million | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥379.81 Million | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥315.21 Million | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥95.77 Million | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥56.87 Million | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥73.46 Million | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥92.49 Million | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥124.02 Million | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥47.76 Million | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥44.42 Million | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥26.83 Million | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥30.82 Million | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥52.71 Million | CN¥36.88 Million | CN¥52.71 Million | — |